Victory Capital Management’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,455
| Closed | -$701K | – | 2482 |
|
|
2025
Q3 | $701K | Buy |
10,455
+8,547
| +448% | +$615K | ﹤0.01% | 1975 |
|
|
2025
Q2 | $180K | Sell |
1,908
-6,798
| -78% | -$746K | ﹤0.01% | 2266 |
|
|
2025
Q1 | $1.03M | Sell |
8,706
-130
| -1% | -$17.7K | ﹤0.01% | 1789 |
|
|
2024
Q4 | $1.17M | Sell |
8,836
-5,165
| -37% | -$634K | ﹤0.01% | 1731 |
|
|
2024
Q3 | $1.82M | Buy |
14,001
+6,643
| +90% | +$781K | ﹤0.01% | 1509 |
|
|
2024
Q2 | $638K | Sell |
7,358
-594
| -7% | -$62.2K | ﹤0.01% | 1900 |
|
|
2024
Q1 | $873K | Buy |
7,952
+3,138
| +65% | +$316K | ﹤0.01% | 1801 |
|
|
2023
Q4 | $504K | Sell |
4,814
-1,082
| -18% | -$105K | ﹤0.01% | 1994 |
|
|
2023
Q3 | $619K | Sell |
5,896
-216
| -4% | -$27.7K | ﹤0.01% | 1885 |
|
|
2023
Q2 | $785K | Sell |
6,112
-1,023
| -14% | -$156K | ﹤0.01% | 1788 |
|
|
2023
Q1 | $1.25M | Sell |
7,135
-1,928
| -21% | -$345K | ﹤0.01% | 1580 |
|
|
2022
Q4 | $1.51M | Sell |
9,063
-4,464
| -33% | -$699K | ﹤0.01% | 1541 |
|
|
2022
Q3 | $1.91M | Sell |
13,527
-244
| -2% | -$44.5K | ﹤0.01% | 1467 |
|
|
2022
Q2 | $2.81M | Sell |
13,771
-1,722
| -11% | -$377K | ﹤0.01% | 1374 |
|
|
2022
Q1 | $3.68M | Buy |
15,493
+1,633
| +12% | +$443K | ﹤0.01% | 1347 |
|
|
2021
Q4 | $4.55M | Buy |
13,860
+3,171
| +30% | +$995K | ﹤0.01% | 1349 |
|
|
2021
Q3 | $3.23M | Buy |
10,689
+1,563
| +17% | +$444K | ﹤0.01% | 1449 |
|
|
2021
Q2 | $2.48M | Sell |
9,126
-2,041
| -18% | -$518K | ﹤0.01% | 1571 |
|
|
2021
Q1 | $2.72M | Buy |
11,167
+9,168
| +459% | +$2.52M | ﹤0.01% | 1555 |
|
|
2020
Q4 | $573K | Buy |
1,999
+251
| +14% | +$69.1K | ﹤0.01% | 2013 |
|
|
2020
Q3 | $445K | Sell |
1,748
-67
| -4% | -$15.9K | ﹤0.01% | 2008 |
|
|
2020
Q2 | $393K | Sell |
1,815
-2,345
| -56% | -$541K | ﹤0.01% | 2066 |
|
|
2020
Q1 | $940K | Buy |
4,160
+2,103
| +102% | +$519K | ﹤0.01% | 1873 |
|
|
2019
Q4 | $513K | Buy |
2,057
+727
| +55% | +$170K | ﹤0.01% | 1997 |
|
|
2019
Q3 | $316K | Buy |
1,330
+499
| +60% | +$115K | ﹤0.01% | 2058 |
|
|
2019
Q2 | $203K | Sell |
831
-1,451
| -64% | -$338K | ﹤0.01% | 1415 |
|
|
2019
Q1 | $526K | Sell |
2,282
-99,988
| -98% | -$22.6M | ﹤0.01% | 1319 |
|
|
2018
Q4 | $21.3M | Buy |
102,270
+275
| +0.3% | +$53.6K | 0.05% | 531 |
|
|
2018
Q3 | $18.9M | Sell |
101,995
-6,050
| -6% | -$1.22M | 0.04% | 622 |
|
|
2018
Q2 | $22.8M | Sell |
108,045
-60,891
| -36% | -$10.7M | 0.05% | 563 |
|
|
2018
Q1 | $25.1M | Sell |
168,936
-3,838
| -2% | -$523K | 0.05% | 530 |
|
|
2017
Q4 | $21.5M | Buy |
172,774
+25,306
| +17% | +$3.54M | 0.05% | 560 |
|
|
2017
Q3 | $22M | Buy |
147,468
+15,580
| +12% | +$2.2M | 0.05% | 550 |
|
|
2017
Q2 | $18.9M | Sell |
131,888
-584
| -0.4% | -$83K | 0.04% | 592 |
|
|
2017
Q1 | $16.3M | Sell |
132,472
-4,000
| -3% | -$490K | 0.04% | 626 |
|
|
2016
Q4 | $16.8M | Sell |
136,472
-22,950
| -14% | -$2.86M | 0.04% | 610 |
|
|
2016
Q3 | $18.2M | Buy |
159,422
+17,197
| +12% | +$1.96M | 0.05% | 584 |
|
|
2016
Q2 | $17.5M | Buy |
142,225
+3,800
| +3% | +$409K | 0.07% | 436 |
|
|
2016
Q1 | $13.3M | Buy |
138,425
+19,125
| +16% | +$1.72M | 0.06% | 477 |
|
|
2015
Q4 | $11.9M | Buy |
119,300
+26,575
| +29% | +$2.84M | 0.05% | 474 |
|
|
2015
Q3 | $10.3M | Buy |
+92,725
| New | +$9.8M | 0.04% | 495 |
|
Other funds holding MLAB
LPP
RIM
GCM
RA
KCM
Victory Capital Management's MLAB Position: Q4 2025 in Review
Victory Capital Management sold out of Mesa Laboratories (MLAB) in Q4 2025, closing a stake of 10,455 shares — an estimated $701K sold.
Victory Capital Management first reported a position in MLAB in Q3 2015 and held it in 41 quarters. The position peaked at $25.1M in Q1 2018. 159 funds tracked by Wall St. Rank hold MLAB as of Q4 2025.
- Victory Capital Management reported no remaining Mesa Laboratories position as of Q4 2025 after selling out during the quarter.
- Victory Capital Management sold 10,455 Mesa Laboratories shares in Q4 2025, an estimated $701K.
- Victory Capital Management first reported a position in Mesa Laboratories in Q3 2015 and held it in 41 quarters.
- Victory Capital Management's Mesa Laboratories position peaked at $25.1M in Q1 2018.
- 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2025.
Based on Victory Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.